Skip to main content
SpringerLink
Log in

Isolierte Thoraxperfusion mit Chemofiltration (ITP-F) beim fortgeschrittenen und vorbehandelten nicht kleinzelligen Bronchialkarzinom

  • Chapter
Regionale Therapie maligner Tumoren

  • 1138 Accesses

Zusammenfassung

Das Bronchialkarzinom ist die häufigste Krebstodesursache beim Mann. Jährlich sterben etwa 500.000 Patienten in der nördlichen Hemisphäre an Lungenkrebs, weltweit sind es über eine Million. Der Anteil des nicht kleinzelligen Karzinoms (NSCLC) liegt bei 80% aller Patienten mit Bronchialkarzinom.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ando Masahiko, Okamoto Isamu, Yamamoto Nobuyuki, Takeda Koji, Tamura Kenji, Seto Takashi, Ariyoshi Yutaka, and Fukuoka Masahiro: Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non- Small-Cell Lung Cancer Patients Treated With Gefinitib. J Clin Oncol 24:2549–2556, 2006.

    Article  PubMed  CAS  Google Scholar 

  2. Hapani Sanjaykumar, Chu David, Wu Shenhong: Risk of gastrointestinal perforation in patients with cancer treated with Bevacizumab: a meta-analysis. Lancet Oncol 2009;10:559–568.

    Article  PubMed  CAS  Google Scholar 

  3. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311:899–909, 1995.

    Google Scholar 

  4. Soon Yu Yang, Stockler Martin R., Askie Lisa M., and Boyer Michael J.: Duration of Chemotherapy for Advanced Non- Small-Cell Lung Cancer: A Systematic Review and Meta- Analysis of Randomized Trials. J Clin Oncol 27:3277–3283, 2009 by American Society of Clinical Oncology.

    Google Scholar 

  5. Aigner KR, Selak E: Isolated Thoracic Perfusion as Induction Chemotherapy for Non-Small-Cell Lung Cancer. Submitted for publication.

    Google Scholar 

  6. Woodward Rebecca M., Brown Martin L., Stewart Susan T., Cronin Kathleen A., Cutler David M.: The Value of Medical Interventions for Lung Cancer in the Elderly. Results from SEER-CMHSF. DOI 10.1002/cncr.23058. Published online 22 October 2007 in Wiley InterScience (www.interscience.wiley.com).

  7. American Joint Committee on Cancer (AJCC) Cancer Staging Handbook Sixth Edition, Eds.: Frederick L. Greene, David L. Page, Irvin D. Flaming, April G. Fritz, Charles M. Balch, Daniel G. Haller, Monica Morrow. 2002 Springer New York Berlin Heidelberg pp 191–202.

    Google Scholar 

  8. Fidias PM, Dakhil SR, Lyss AP, et al: Phase III study of immediate compared with delayed docetaxel after frontline therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 27:591–598, 2009.

    Article  PubMed  CAS  Google Scholar 

  9. Johnson David H., Fehrenbacher Louis, Novotny William F., Herbst Roy S., Nemunaitis John J., Jablons David M., Langer J. Corey, DeVore III Russell F., Gaudreault Jacques, Damico Lisa A., Holmgren Eric, and Kabbinavar Fairooz. RandomizedPhase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer. J Clin Oncol 22:2184–2191, 2004 by American Society of Clinical Oncology.

    Google Scholar 

  10. Mok Tony S.K., Wu Yi-Long, Yu Chong-Jen, Thou Caicun, Chen Yuh-Min, Zhang Li, Ignacio Jorge, Liao Meilin, Srimuninnimit Vichien, Boyer Michael J., Chua-Tan Marina, Sriuranpong Virote, Sudoyo Aru W., Jin Kate, Johnston Michael, Chui Winsome, and Lee Jin-Soo.: Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 27:5080–5087, 2009 by American Society of Clinical Oncology.

    Google Scholar 

  11. Nasser Hanna, Paul A. Bunn Jr, Corey Langer, et al: Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell-Lung Cancer. J Clin Oncol 24:2038–2043, 2006.

    Article  Google Scholar 

  12. Niho Seiji, Kubota Kaoru, Goto Koichi, Yoh Kiyotaka, Ohmatsu Hironobu, Kakinuma Ryutaro, Saijo Nagahiro, and Nishiwaki Yutaka: First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Phase II Study. J Clin Oncol 24:64–69, 2006 by American Society of Clinical Oncology.

    Google Scholar 

  13. Riely Gregory J., Rizvi Naiyer A., Kris Mark G., Milton Daniel T., Solit David B., Rosen Neal, Sentruk Emir, Azzoli Christopher G., Brahmer Julie R., Sirotnak Francis M., Seshan Venkatraman E., Fogle Margaret, Ginsberg Michelle, Miller Vincent A., and Rudin Charles M.: Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 27:264– 270, 2009 by American Society of Clinical Oncology.

    Google Scholar 

  14. Scagliotti GV, Parikh P, von Pawel J, et al: Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced- stage non-small-cell lung cancer. J Clin Oncol 26: 3543–3551, 2008.

    Article  PubMed  CAS  Google Scholar 

  15. Socinski MA, Stinchcombe TE: Duration of first line chemotherapy in advanced non-small cell lung cancer: Less is more in the era of effective subsequent therapies. J Clin Oncol 25:5155–5157, 2007.

    Article  PubMed  CAS  Google Scholar 

  16. Stinchcombe TE, Socinski MA: Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of therapy. J Thorac Oncol 4:243–250, 2009.

    Article  PubMed  Google Scholar 

  17. Aigner KR, Müller H, Walter H et al. Drug filtration in highdose regional chemotherapy. Eds: Aigner KR et al. Contrib Oncol 1988; 29: 261–280.

    Google Scholar 

  18. Aigner KR, Tonn JC, Hechtel R, Seuffer R. Die intraarterielle Zytostatikatherapie mit venöser Filtration im halboffenen System. Onkologie 1983; 6 (2): 2–4.

    Article  Google Scholar 

  19. Muchmore JH, Aigner KR, Beg MH. Regional Chemotherapy for Advanced Intraabdominal and Pelvic Cancer in: Cancer of the Colon, Rectum and Anus. Eds: Cohen AM, Winawer SJ, Friedman MA, Günderson LL. 1995; 881–889.

    Google Scholar 

  20. Tonn JC. Die portocavale Hämofiltration bei der isolierten Perfusion der Leber. In: Hrg. Aigner KR, Beitr. Onkol. 1985; 21: 108–116.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Onkologische Chirurgie, Medias Klinikum GmbH & Co. KG, Krankenhausstraße 14a, 84489, Burghausen, Deutschland

    Prof. Dr. Karl R. Aigner & Emir Selak MD

Authors
  1. Prof. Dr. Karl R. Aigner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emir Selak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medias Klinikum Burghausen, Burghausen

    Karl Reinhard Aigner

  2. University of Sydney, Sydney, Australia

    Frederick O. Stephens

  3. Universitätsklinikum Frankfurt, Frankfurt

    Thomas J. Vogl

  4. Universitätsklinikum Gießen, Gießen

    Winfried Padberg

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Aigner, K.R., Selak, E. (2013). Isolierte Thoraxperfusion mit Chemofiltration (ITP-F) beim fortgeschrittenen und vorbehandelten nicht kleinzelligen Bronchialkarzinom. In: Aigner, K.R., Stephens, F.O., Vogl, T.J., Padberg, W. (eds) Regionale Therapie maligner Tumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35014-6_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35014-6_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35013-9

  • Online ISBN: 978-3-642-35014-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation